RIL
SLS icon

Rothschild Investment LLC’s SELLAS Life Sciences SLS Stock Holding History

Rothschild Investment LLC’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.15K Buy
146
+19
+15% +$131 ﹤0.01% 2728
2026
Q1 		$537 Buy
127
+106
+505% +$474 ﹤0.01% 3106
2025
Q4 		$79 Buy
+21
New +$41 ﹤0.01% 3236

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DI
DAGCO Inc Westlake, Ohio $541M AUM 29.31% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
OCG
Opus Capital Group Cincinnati, Ohio $1.03B AUM 20.67% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Rothschild Investment LLC's SLS Position: Q2 2026 in Review

Rothschild Investment LLC increased its SELLAS Life Sciences (SLS) stake by 15% in Q2 2026, buying an estimated $131 and bringing the position to 146 shares worth $2.15K. The position accounts for ﹤0.01% of the portfolio, ranked #2728.

Rothschild Investment LLC first reported a position in SLS in Q4 2025 and has held it in 3 quarters since. 84 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Rothschild Investment LLC held 146 shares of SELLAS Life Sciences worth $2.15K as of Q2 2026.
  • Rothschild Investment LLC bought 19 SELLAS Life Sciences shares in Q2 2026, an estimated $131.
  • SELLAS Life Sciences made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2728 holding.
  • Rothschild Investment LLC first reported a position in SELLAS Life Sciences in Q4 2025 and has held it in 3 quarters since.
  • 84 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.